Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Cronos Group Inc (CRON) Price & Performance

Ascendis Pharma A/STrade
Cronos Group IncTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Cronos Group Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Ascendis Pharma A/S is far larger — about 14.6× Cronos Group Inc's market cap. Which is the better fit depends on your goals.

ASNDCRON
Market Cap
$16.67B$1.14B
Sector
HealthHealth
52-Week High
$277.18$3.27
52-Week Low
$189.74$2.30
Enterprise Value
$17.04B$341.13M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON